Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.51% to 1,713.40 Indian rupees Monday, on what proved to be an ...

Sun Pharmaceutical Industries Ltd. closed 13.20% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

12 May, 2015 16 Mar, 2016 5:116 244 For every 116 shares held; holder is entitled to apply 5 rights shares at a premium of RS 244 14 Jul, 2011 23 Aug, 2012 1:7 66 For every 7 shares held; holder ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of deal announcements. Paul Little, CEO of Vesper Bio, agreed ...

Sun Pharmaceutical Industries or Sun Pharma is India’s leading pharmaceutical firm which is known for the production of Active Pharmaceutical Ingredients (APIs). The company is headquartered in ...

India has established itself as a global leader in pharmaceutical production, with potential for further growth through increased investment in drug discovery. Companies like Sun Pharma are already ...

US tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlights risks to Indian firms like Sun Pharma and Cipla due to ...